Indapta Technologies, Inc is a series a startup based in United States. 2 investors tracked.
Based in the United States, Indapta Technologies, Inc is a startup founded in 2018. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Indapta Therapeutics is harnessing the unique power of Vδ1 gamma-delta (Vδ1) T cells to develop novel allogeneic cell therapies for the treatment of cancer. The company is focused on overcoming the challenges of current cell therapies by utilizing the inherent properties of Vδ1 T cells to create potent, allogeneic, off-the-shelf cell therapies for a wide range of cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.